These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 13910951)

  • 1. Mechanism of experimental tumorigenesis. 9. Sulfhydryl groups, disulfide bonds, and birefringence in mouse epidermis after exposure to dipole-type tumor promoter and carcinogen.
    SETALA K; AYRAPAA O; NISKANEN EE
    Acta Pathol Microbiol Scand; 1962; 54():39-58. PubMed ID: 13910951
    [No Abstract]   [Full Text] [Related]  

  • 2. [The opposing action of carcinogen and tumor producers on keratinizing tissue (mouse epidermis)].
    SETALA K
    Verh Dtsch Ges Pathol; 1961; 45():223-6. PubMed ID: 13910956
    [No Abstract]   [Full Text] [Related]  

  • 3. The study of tumor promotion in a cell culture model for mouse skin--a tissue that exhibits multistage carcinogenesis in vivo.
    Yuspa SH; Hennings H; Kulesz-Martin M; Lichti U
    Carcinog Compr Surv; 1982; 7():217-30. PubMed ID: 6121622
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the mechanism of artificial tumorigenesis. XII. Light- and polarization-microscopic changes in the epidermis of tumor-sensitive CF 1 mice and CFW mice of the Swiss group induced with Tween 60].
    SETALA K; NISKANEN EE; NYYSSONEN O; LINDROOS B
    Acta Pathol Microbiol Scand Suppl; 1962; Suppl 155():47-105. PubMed ID: 13910953
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of an in vitro model to study carcinogen-induced neoplastic progression of initiated mouse epidermal cells.
    Morgan D; Welty D; Glick A; Greenhalgh D; Hennings H; Yuspa SH
    Cancer Res; 1992 Jun; 52(11):3145-56. PubMed ID: 1375535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [On the mechanism of artifical tumorigenesis. XIII. Ultrastructural changes in the epidermis of tumor-sensitive CF 1 mice and CFW mice of the Swiss group, induced with Tween 60].
    SETALA K; NISKANEN EE; NYHOLM M; STJERNVALL L; NYYSSONEN O
    Acta Pathol Microbiol Scand Suppl; 1962; Suppl 155():107-41. PubMed ID: 13910952
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanism of experimental tumorigenesis. I. Epidermal hyperplasia in mouse caused by locally applied tumor initiator and dipoletype tumor promotor.
    SETALA K; MERENMIES L; STJERNVALL L; AHO Y; KAJANNE P
    J Natl Cancer Inst; 1959 Nov; 23():925-51. PubMed ID: 14445175
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanism of experimental tumorigenesis. II. Effect of mole ratio distribution of span 60 and span 20 derivatives on hyperplasia in mouse epidermis.
    SETALA K; MERENMIES L; STJERNVALL L; AHO Y
    J Natl Cancer Inst; 1959 Nov; 23():953-67. PubMed ID: 14445177
    [No Abstract]   [Full Text] [Related]  

  • 9. Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation.
    Capozza F; Williams TM; Schubert W; McClain S; Bouzahzah B; Sotgia F; Lisanti MP
    Am J Pathol; 2003 Jun; 162(6):2029-39. PubMed ID: 12759258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor promoting effects of some long chain fatty acids in experimental skin carcinogenesis in the mouse.
    HOLSTI P
    Acta Pathol Microbiol Scand; 1959; 46(1):51-8. PubMed ID: 13669989
    [No Abstract]   [Full Text] [Related]  

  • 11. Tumor-promoting effects in mouse skin; comparison between oleic acid, sorbitan mono-oleate (span 80), and polyoxyethylene sorbitan mono-oleate (tween 80).
    HOLSTI P
    Ann Med Exp Biol Fenn; 1959; 37():212-5. PubMed ID: 14402841
    [No Abstract]   [Full Text] [Related]  

  • 12. Specificity and mechanism(s) of promoter inhibitors in multistage promotion.
    Slaga TJ; Fischer SM; Weeks CE; Nelson K; Mamrack M; Klein-Szanto AJ
    Carcinog Compr Surv; 1982; 7():19-34. PubMed ID: 7039828
    [No Abstract]   [Full Text] [Related]  

  • 13. Factors influencing the incidence of epidermal methylcholanthrene tumors in mice treated with cortisone. II. Influence of variations in the timing of cortisone administration in relation to carcinogen application.
    HERRMANN F; SHERWIN RW; MORRILL SD; ROTHSTEIN MJ; SULZBERGER MB
    J Invest Dermatol; 1955 Dec; 25(6):411-21. PubMed ID: 13286529
    [No Abstract]   [Full Text] [Related]  

  • 14. [STUDIES ON DIFFERENT EFFECTS OF COCARCINOGENS AND CARCINOGENS ON THE MOUSE EPIDERMIS].
    DOERMER P; OCHLERT W
    Beitr Pathol Anat; 1964 Feb; 129():307-30. PubMed ID: 14150767
    [No Abstract]   [Full Text] [Related]  

  • 15. Deregulated minichromosomal maintenance protein MCM7 contributes to oncogene driven tumorigenesis.
    Honeycutt KA; Chen Z; Koster MI; Miers M; Nuchtern J; Hicks J; Roop DR; Shohet JM
    Oncogene; 2006 Jul; 25(29):4027-32. PubMed ID: 16518415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of erbB2 and c-src in phorbol ester-treated mouse epidermis: possible role in mouse skin tumor promotion.
    Xian W; Rosenberg MP; DiGiovanni J
    Oncogene; 1997 Mar; 14(12):1435-44. PubMed ID: 9136987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological and histochemical study of the early lesions of mouse skin after a single application of 4-nitroquinoline N-oxide.
    HAYASHI Y
    Gan; 1959 Sep; 50():219-26. PubMed ID: 14400298
    [No Abstract]   [Full Text] [Related]  

  • 18. LKB1 deficiency sensitizes mice to carcinogen-induced tumorigenesis.
    Gurumurthy S; Hezel AF; Sahin E; Berger JH; Bosenberg MW; Bardeesy N
    Cancer Res; 2008 Jan; 68(1):55-63. PubMed ID: 18172296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the epidermal growth factor receptor by skin tumor promoters and in skin tumors from SENCAR mice.
    Xian W; Kiguchi K; Imamoto A; Rupp T; Zilberstein A; DiGiovanni J
    Cell Growth Differ; 1995 Nov; 6(11):1447-55. PubMed ID: 8562483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphological alterations in the mouse skin induced by synthesised surfactant type tumour promoters.
    SETALA K; STJERNVALL L; MERENMIES L; HOLSTI P; KAJANNE P; AHO Y
    Acta Unio Int Contra Cancrum; 1959; 15():680-5. PubMed ID: 14445180
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.